Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.



Current Issue

Zofran MDL Judge Refuses to Dismiss Fraud-Based Claims as to Drug Labeling

The Massachusetts federal judge overseeing the Zofran multidistrict litigation has refused to dismiss claims accusing GlaxoSmithKline of making misrepresentations in the anti-nausea drug’s labeling concerning the risk of birth defects, finding they were pled with the requisite particularity.

Calif. Federal Judge Remands Onglyza Action, Says Claims Against McKesson May be Viable

A California federal judge has remanded an Onglyza action to state court, ruling that non-diverse defendant McKesson Corp. failed to show that the claims against it are obviously without merit under state law.

Sanctions Must Be Limited to Fees Incurred Due to Bad Faith Conduct, High Court Rules

In sanctioning a party’s bad faith litigation conduct by ordering it to pay the other party’s legal fees, the award must be limited to the fees the innocent party incurred solely due to the misconduct, the U.S. Supreme Court has unanimously held.

Ill. Federal Jury Awards Attorney’s Widow $3 Million in Paxil Suicide Action

An Illinois federal jury has awarded $3 million to the widow of a law firm partner who committed suicide after ingesting generic Paxil, finding GlaxoSmithKline failed to adequately warn the decedent’s doctor of the antidepressant’s increased risk of suicidal behavior in adults of all ages.

Parties Submit Briefs to U.S. Supreme Court in Plavix Personal Jurisdiction Battle

The parties have filed their briefs before the U.S. Supreme Court in a dispute over whether California courts have personal jurisdiction over Bristol-Myers Squibb Co. in eight Plavix actions involving nearly 600 non-residents pursuant to Code of Civil Procedure Section 410.10, which extends jurisdiction to the maximum extent permissible under the U.S. Constitution.

Lack of Expert Testimony Defeats Claims in Teva IUD Lawsuit, Ind. Federal Judge Rules

An Indiana federal judge has awarded Teva North America summary judgment in an action involving its allegedly defective ParaGard intrauterine contraceptive device, ruling that the plaintiff’s failure to produce expert reports defeats her claims.

IVC Filter Plaintiffs Did Not Seek Joint Trial Under CAFA, 9th Cir. Affirms

A request for consolidation or coordination and a bellwether trial process made by the plaintiffs in eight IVC filter actions does not constitute a request for a joint trial under the Class Action Fairness Act, because they did not seek a bellwether trial that would have a preclusive effect on all cases, a federal appellate court has held.

Davol, Bard Prevail in Fla. Federal Hernia Repair Patch Action

A Florida federal judge has awarded summary judgment to the makers of a hernia repair patch on failure-to-warn and design defect claims after excluding the plaintiffs’ expert witness, whose testimony was the only evidence proffered in support of the plaintiff's claim that the memory recoil ring broke in the patch.

Ind. Federal Judge Allows IPLA Claims to Proceed Against Medtronic in Defibrillator Action

A woman who was injured by an allegedly defective Medtronic defibrillator has adequately pled claims under the Indiana Products Liability Act, a federal judge has ruled, finding the complaint “clearly states a product liability claim for personal injuries” under the Act.

Bair Hugger Plaintiffs Not Entitled to VitaHEAT Device Docs, MDL Judge Rules

The judge overseeing the Bair Hugger Forced Air Warming Devices MDL has held that the plaintiffs are not entitled to documents concerning another patient-warming system because they do not establish that a safer alternative design existed for the Bair Hugger.

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.